The global Next-generation Sequencing Library Preparation market size was valued at USD 2145.9 million in 2025 and is projected to reach USD 8010.9 million by 2035, expanding at a CAGR of 14.08% from 2026 to 2035. Market growth is driven by expanding precision medicine, increasing genome sequencing projects, rising oncology and rare disease testing, and continuous advancements in automated library preparation technologies.
|
Years |
2022 |
2023 |
2024 |
2025 |
2026 |
2027 |
2028 |
2029 |
2030 |
2031 |
2032 |
2033 |
2034 |
2035 |
|
Revenue (USD Mn) |
1515.2 |
XX |
XX |
2145.9 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
8010.9 |
|
Region |
2022 |
2023 |
2024 |
2025 |
2026 |
2027 |
2028 |
2029 |
2030 |
2031 |
2032 |
2033 |
2034 |
2035 |
|
North America |
XX |
XX |
XX |
967.8 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
3227.5 |
|
Europe |
XX |
XX |
XX |
536.4 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
1870 |
|
Asia Pacific |
XX |
XX |
XX |
472 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
2269.2 |
|
Latin America |
XX |
XX |
XX |
66.5 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
262.1 |
|
Middle East & Africa |
XX |
XX |
XX |
103 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
381.8 |
|
2025 |
2026 |
2027 |
2028 |
2029 |
2030 |
2031 |
2032 |
2033 |
2034 |
2035 |
|
|
Conservative |
2145.9 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
7349.1 |
|
Likely |
2145.9 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
8010.9 |
|
Optimistic |
2145.9 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
12016.3 |
The rapid expansion of precision medicine programs and government-supported genome sequencing initiatives is one of the strongest growth drivers for the Next-generation Sequencing (NGS) Library Preparation Market. As healthcare systems increasingly integrate genomic information into disease diagnosis, treatment selection, and preventive medicine, the demand for high-quality library preparation kits, reagents, and automated workflows continues to rise.
Library preparation represents a critical step in NGS workflows because it directly influences sequencing accuracy, coverage, and reproducibility across oncology, rare disease, reproductive health, and infectious disease applications. Consequently, hospitals, reference laboratories, pharmaceutical companies, and research institutes are investing in advanced library preparation technologies that deliver higher throughput, reduced hands-on time, and improved data quality.
Government-funded genomics initiatives continue to strengthen this demand. According to the U.S. National Institutes of Health (NIH), the All of Us Research Program has generated genomic data from nearly 250,000 participants and identified more than 275 million previously unreported genetic variants, significantly expanding genomic resources for clinical and biomedical research. Earlier, NIH also released its first dataset containing nearly 100,000 whole genome sequences and genotyping data from 165,000 participants, creating one of the world's most diverse genomic databases.
Furthermore, the American Society of Human Genetics (ASHG) reports that the cost of sequencing a complete human genome has declined from approximately US$100 million in 2001 to around US$500 by 2024, enabling broader adoption of genome sequencing in clinical practice and research. These developments substantially increase the demand for reliable, scalable, and automation-compatible library preparation solutions capable of supporting large-volume sequencing projects and precision medicine programs worldwide.
The increasing adoption of automated library preparation systems is transforming next-generation sequencing workflows across clinical diagnostics, pharmaceutical research, biotechnology companies, and academic laboratories. Manual library preparation often involves multiple complex steps, including nucleic acid fragmentation, end repair, adapter ligation, amplification, and purification, making workflows labor-intensive and susceptible to human error.
Automation significantly improves workflow standardization, minimizes sample variability, reduces contamination risks, and increases throughput, enabling laboratories to process hundreds or thousands of samples efficiently while maintaining high reproducibility. These advantages are becoming increasingly important as sequencing volumes continue to expand across oncology, infectious disease surveillance, hereditary disease testing, pharmacogenomics, and population-scale genomic studies.
Advancements in robotic liquid handling platforms, integrated sample preparation instruments, magnetic bead-based purification systems, and AI-assisted workflow optimization have further accelerated the transition toward automated library preparation. Modern solutions also support multiplexing, low-input DNA and RNA samples, single-cell sequencing, long-read sequencing, and multi-omics applications, allowing laboratories to maximize sequencing efficiency while reducing turnaround time and operational costs.
Pharmaceutical companies increasingly rely on automated library preparation to support biomarker discovery, companion diagnostic development, and clinical trial sequencing, while hospitals and diagnostic laboratories utilize automation to improve consistency in routine genomic testing. As sequencing technologies continue to evolve toward higher throughput and greater clinical adoption, the need for scalable, standardized, and automation-enabled library preparation workflows will remain a critical factor supporting sustained growth in the Next-generation Sequencing Library Preparation Market.
The high cost associated with next-generation sequencing (NGS) library preparation remains a significant restraint for market growth, particularly among small and mid-sized clinical laboratories, academic institutions, and healthcare providers in developing economies. Although sequencing costs have declined substantially over the past decade, library preparation continues to account for a considerable portion of total sequencing expenses due to the need for specialized reagents, sample preparation kits, automation platforms, quality control instruments, and skilled personnel. Laboratories must also invest in laboratory information management systems (LIMS), bioinformatics software, and regulatory compliance, increasing the overall cost of ownership and limiting broader adoption.
According to the U.S. National Human Genome Research Institute (NHGRI), while the cost of producing a human whole genome sequence has declined to below US$1,000, downstream workflow expenses including library preparation, quality assessment, data storage, and bioinformatics remain substantial contributors to total testing costs. In addition, the World Health Organization (WHO) has highlighted that many low- and middle-income countries continue to face challenges in implementing NGS because of limited laboratory infrastructure, high equipment procurement costs, and dependence on imported sequencing consumables.
These financial barriers slow the adoption of advanced genomic testing outside well-funded research institutions and major healthcare centers. Consequently, laboratories often delay upgrading to automated library preparation systems or expanding sequencing capacity, restricting market penetration despite increasing demand for precision medicine and molecular diagnostics.
A persistent shortage of trained professionals capable of performing next-generation sequencing library preparation, sequencing operations, and bioinformatics analysis continues to restrain market expansion. Successful implementation of NGS requires multidisciplinary expertise in molecular biology, genomics, quality assurance, data analysis, and clinical interpretation.
Many hospitals, diagnostic laboratories, and research institutes, particularly in emerging markets, face difficulties recruiting and retaining qualified personnel, resulting in underutilization of sequencing infrastructure and slower adoption of advanced library preparation technologies. The challenge becomes even greater as laboratories transition toward automated and high-throughput sequencing workflows that require specialized technical knowledge for validation, troubleshooting, and data management.
The World Health Organization (WHO) has emphasized that strengthening workforce capacity is a critical requirement for expanding NGS implementation, noting that genomic surveillance and sequencing programs increasingly depend on trained laboratory scientists and bioinformatics specialists. Similarly, publications supported by international genomics organizations highlight that shortages in genomics education, laboratory training, and bioinformatics expertise remain major barriers to widespread adoption of sequencing technologies, particularly in resource-constrained regions.
As sequencing applications continue to expand across oncology, infectious disease surveillance, reproductive health, and precision medicine, the demand for highly skilled professionals is expected to outpace workforce development. Without sustained investments in specialized training programs, laboratory education, and bioinformatics capacity building, the shortage of qualified personnel will continue to limit the efficient deployment and scalability of NGS library preparation technologies worldwide.
The rapid expansion of national genome sequencing initiatives and population-scale genomics programs presents a significant opportunity for the Next-generation Sequencing (NGS) Library Preparation Market. Governments, healthcare organizations, and research institutes are increasingly investing in large genomic databases to improve disease prevention, accelerate precision medicine, and advance biomedical research. These initiatives require standardized, high-throughput, and automation-compatible library preparation workflows capable of processing hundreds of thousands of DNA and RNA samples with high reproducibility.
As sequencing programs continue to expand, demand for advanced library preparation kits, automated sample preparation platforms, and high-quality reagents will increase substantially. Companies offering scalable, cost-effective, and automation-ready solutions are well positioned to capitalize on long-term procurement opportunities from national healthcare systems, biobanks, academic institutions, and pharmaceutical research organizations.
The U.S. National Institutes of Health (NIH) All of Us Research Program announced in February 2025 that its research dataset had expanded to include more than 633,000 participants, representing a 50% increase from the previous release. In addition, the genomic dataset now contains whole genome sequences from more than 414,000 participants, making it one of the world's largest precision medicine resources.
Such large-scale sequencing initiatives significantly increase demand for reliable library preparation technologies that enable efficient processing of diverse biological samples while maintaining sequencing accuracy and workflow consistency. Similar national genomics programs being implemented across Europe, Asia-Pacific, and the Middle East are expected to further strengthen long-term market opportunities for NGS library preparation solution providers.
|
By Offerings |
2025 |
|
Products |
74.6% |
|
Services |
25.4% |
The Products segment accounted for the largest share of the Next-generation Sequencing Library Preparation Market due to the widespread use of library preparation kits, reagents, adapters, enzymes, beads, and consumables in every sequencing workflow. Continuous product innovations, increasing automation compatibility, and growing adoption of NGS in clinical diagnostics, oncology, and genomics research continue to strengthen segment dominance.
The Services segment is projected to witness the fastest growth during the forecast period, driven by increasing outsourcing of sequencing workflows to contract research organizations and specialized genomic service providers. Rising demand for cost-effective library preparation, bioinformatics support, custom sequencing services, and expanding pharmaceutical research collaborations is accelerating market growth.
The Diagnostics segment held the largest share of the Next-generation Sequencing Library Preparation Market, driven by the growing adoption of NGS in oncology, rare disease diagnosis, infectious disease detection, and reproductive health testing. Increasing implementation of precision medicine, companion diagnostics, and clinical genomic testing has significantly boosted demand for high-quality library preparation solutions.
The Drug Discovery & Development segment is expected to register the fastest growth during the forecast period due to increasing use of NGS for biomarker discovery, target identification, pharmacogenomics, and clinical trial research. Rising pharmaceutical and biotechnology R&D investments, coupled with expanding multi-omics applications, are accelerating demand for advanced library preparation technologies.
The Sequencing By Synthesis (SBS) segment dominated the Next-generation Sequencing Library Preparation Market owing to its high sequencing accuracy, scalability, and broad adoption in clinical diagnostics, oncology, whole-genome sequencing, and transcriptomics. Strong compatibility with automated library preparation workflows and extensive use by research institutions and healthcare laboratories continue to reinforce its market leadership.
The Nanopore Sequencing segment is projected to witness the fastest growth during the forecast period, driven by increasing demand for real-time sequencing, long-read genomic analysis, portable sequencing devices, and rapid infectious disease surveillance. Continuous technological advancements and expanding applications in clinical diagnostics, environmental genomics, and field-based research are accelerating adoption.
The Consumables segment accounted for the largest share of the Next-generation Sequencing Library Preparation Market due to the recurring demand for library preparation kits, enzymes, adapters, primers, beads, and reagents across every sequencing workflow. Continuous utilization in clinical diagnostics, pharmaceutical research, and academic genomics, coupled with frequent replenishment requirements, sustains the segment's market dominance.
The Bioinformatics Tools segment is anticipated to register the fastest growth during the forecast period, driven by increasing volumes of sequencing data and the need for efficient data processing, analysis, and interpretation. Growing adoption of AI-enabled analytics, cloud-based genomic platforms, and integrated bioinformatics solutions is accelerating demand across research and clinical laboratories.
The Sequencing segment held the largest share of the Next-generation Sequencing Library Preparation Market, driven by its central role in genomic workflows and widespread adoption across clinical diagnostics, oncology, rare disease testing, and biomedical research. Continuous advancements in high-throughput sequencing platforms and increasing sample volumes continue to strengthen the segment's market leadership.
The Data Analysis segment is expected to witness the fastest growth during the forecast period due to the exponential increase in genomic data generated by next-generation sequencing. Rising adoption of AI-powered bioinformatics platforms, cloud-based analytics, and precision medicine applications is driving demand for advanced data analysis solutions across clinical and research settings.
The Academic & Research Institutes segment accounted for the largest share of the Next-generation Sequencing Library Preparation Market, driven by extensive genomics research, government-funded sequencing projects, and increasing adoption of NGS for basic, translational, and population genomics studies. Continuous investments in research infrastructure and collaborative scientific programs further support the segment's dominance.
The Clinical & Diagnostics Laboratories segment is projected to register the fastest growth during the forecast period, fueled by increasing adoption of NGS for oncology, rare disease, reproductive health, and infectious disease diagnostics. Rising implementation of precision medicine, expanding reimbursement support, and growing demand for high-throughput genomic testing are accelerating segment growth.
The Sequencing Services segment held the largest share of the Next-generation Sequencing Library Preparation Market, driven by increasing outsourcing of sequencing workflows by pharmaceutical companies, biotechnology firms, academic institutions, and clinical laboratories. The availability of cost-effective, high-throughput sequencing capabilities and advanced technical expertise continues to strengthen demand for outsourced sequencing services.
The Bioinformatics & Data Analysis Services segment is expected to witness the fastest growth during the forecast period, fueled by the rapid expansion of genomic datasets and increasing demand for accurate sequence interpretation. Growing adoption of AI-powered analytics, cloud computing, and integrated genomic data management solutions is accelerating demand across research and clinical applications.
The Sequencing Services segment accounted for the largest share of the Next-generation Sequencing Library Preparation Market due to the growing outsourcing of sequencing projects by pharmaceutical companies, biotechnology firms, academic institutions, and clinical laboratories. High-throughput sequencing capabilities, reduced capital investment, and access to specialized expertise continue to drive the segment's market leadership.
The Data Analysis Services segment is projected to register the fastest growth during the forecast period, driven by the increasing complexity and volume of genomic data generated through NGS. Rising demand for cloud-based bioinformatics platforms, AI-assisted genomic interpretation, and comprehensive data management solutions is significantly accelerating adoption across research and clinical laboratories.
The Academic & Research Institutes segment held the largest share of the Next-generation Sequencing Library Preparation Market, driven by extensive genomic research, government-funded sequencing initiatives, and increasing collaborations with biotechnology and pharmaceutical companies. Continuous investments in life sciences research and growing adoption of NGS across universities and research centers continue to support segment dominance.
The Hospitals & Clinical Laboratories segment is anticipated to witness the fastest growth during the forecast period, fueled by expanding clinical adoption of NGS for oncology, rare disease diagnosis, infectious disease testing, and reproductive health screening. Increasing implementation of precision medicine and demand for rapid, high-quality genomic testing are accelerating the utilization of outsourced NGS services.
|
By Geography |
2022 |
2025 |
2035 |
|
North America |
XX |
967.8 |
3227.5 |
|
US |
XX |
896.1 |
XX |
|
Canada |
XX |
71.6 |
XX |
|
Europe |
XX |
536.4 |
1870 |
|
Germany |
XX |
109.9 |
XX |
|
UK |
XX |
68.6 |
XX |
|
France |
XX |
83.6 |
XX |
|
Italy |
XX |
46.1 |
XX |
|
Spain |
XX |
43.9 |
XX |
|
Switzerland |
XX |
16.6 |
XX |
|
Netherlands |
XX |
11.2 |
XX |
|
Rest of Europe |
XX |
156.1 |
XX |
|
Asia Pacific |
XX |
472 |
2269.2 |
|
China |
XX |
197.8 |
XX |
|
India |
XX |
35.8 |
XX |
|
Japan |
XX |
74.5 |
XX |
|
South Korea |
XX |
67.5 |
XX |
|
Singapore |
XX |
16.9 |
XX |
|
Australia |
XX |
24.5 |
XX |
|
Thailand |
XX |
6.1 |
XX |
|
Malaysia |
XX |
11.8 |
XX |
|
Philippines |
XX |
9.4 |
XX |
|
Indonesia |
XX |
7.5 |
XX |
|
Rest of Asia Pacific |
XX |
19.8 |
XX |
|
Middle East & Africa |
XX |
103 |
381.8 |
|
Saudi Arabia |
XX |
33.7 |
XX |
|
United Arab Emirates |
XX |
26.6 |
XX |
|
South Africa |
XX |
15.5 |
XX |
|
Egypt |
XX |
8.4 |
XX |
|
Israel |
XX |
7.4 |
XX |
|
Rest of MEA |
XX |
11.1 |
XX |
|
Latin America |
XX |
66.5 |
262.1 |
|
Brazil |
XX |
21.8 |
XX |
|
Mexico |
XX |
15.6 |
XX |
|
Argentina |
XX |
7 |
XX |
|
Chile |
XX |
5.7 |
XX |
|
Colombia |
XX |
3.4 |
XX |
|
Peru |
XX |
2.8 |
XX |
|
Rest of LA |
XX |
9.9 |
XX |
North America Next-generation Sequencing Library Preparation market held the largest share of 45.1% of the global market in 2025 and was valued at approximately USD 967.8 million. Market growth is supported by widespread clinical NGS adoption, strong genomics funding, increasing companion diagnostics, and advanced research infrastructure across healthcare and life sciences sectors.
• Expanding Precision Medicine Programs
• Strong Clinical Genomics Funding
• Rising Oncology Sequencing Demand
• Advanced Multi-omics Research Infrastructure
• High Library Preparation Kit Costs
• Complex Regulatory Validation Requirements
• Skilled Workforce Shortage in Genomics Laboratories
• Sample Preparation Workflow Complexity
• AI-Integrated Library Preparation Platforms
• Decentralized Clinical Sequencing Expansion
The U.S. accounted for the dominant share within North America and represented approximately 92.6% of the regional market in 2025. Market growth is fueled by population-scale genome initiatives, growing precision oncology applications, increasing pharmaceutical R&D investments, and expanding adoption of automated NGS library preparation workflows.
• Growing Population-Scale Genome Initiatives
• Increasing Companion Diagnostics Adoption
• Strong Biopharmaceutical R&D Investments
• Broad Adoption of High-Throughput Sequencing
• Reimbursement Variability for NGS Tests
• Stringent Laboratory Compliance Standards
• High Instrument Maintenance Expenses
• Data Interpretation Bottlenecks
• Automated Library Preparation in Clinical Labs
• Expansion of Liquid Biopsy Testing
Canada represented approximately 7.4% of the North American market in 2025 and was valued at around USD 71.6 million. Market growth is driven by government-supported genomics programs, expanding rare disease research, increasing academic sequencing activities, and growing investments in precision healthcare infrastructure.
•Federal Investment in Genomic Innovation
• Expansion of Rare Disease Sequencing Programs
• Growth of Academic Sequencing Centers
• Rising Public Health Genomics Projects
• Limited Commercial Laboratory Density
• Provincial Funding Disparities
• Dependence on Imported Sequencing Reagents
• Remote Sample Logistics Challenges
• Indigenous Genomics Research Initiatives
• Cross-Border Precision Medicine Collaborations
Europe accounted for approximately 25% of the global Next-generation Sequencing Library Preparation market in 2025 and was valued at nearly USD 536.4 million. Market growth is supported by expanding precision medicine initiatives, increasing cancer genomic profiling, strong collaborative research programs, and rising investments in clinical sequencing technologies.
• EU Support for Genomic Research Networks
• Increasing Cancer Molecular Profiling
• Growing Translational Research Programs
• Expansion of Personalized Healthcare
• Fragmented Regulatory Landscape Across Countries
• Diverse Reimbursement Policies
• Cross-Border Data Governance Challenges
• Rising Research Operational Costs
• Pan-European Genomics Partnerships
• Sustainable Library Preparation Technologies
The UK represented approximately 12.8% of the European market in 2025 and was valued at nearly USD 68.6 million. Market growth is driven by advanced molecular diagnostics, increasing translational genomics research, expanding biotechnology innovation, and strong adoption of automated sequencing laboratory solutions.
• National Genomic Medicine Strategy
• Expansion of Whole Genome Sequencing Services
• Strong Academic Research Ecosystem
• Increasing NHS Genomic Testing Adoption
• NHS Budgetary Constraints
• Procurement Delays for Advanced Technologies
• Workforce Capacity Challenges
• Regulatory Transition After Brexit
• Pharmacogenomics Implementation
• Genomics-Based Preventive Healthcare
Germany accounted for approximately 20.5% of the European market in 2025 and was valued at around USD 109.9 million. Market growth is fueled by national genome sequencing programs, expanding NHS genomic services, increasing clinical research activities, and growing demand for precision medicine applications.
• Expanding Precision Oncology Trials
• Strong Molecular Diagnostics Industry
• Advanced Biotechnology Manufacturing Base
• Government Support for Translational Medicine
• Strict Clinical Validation Expectations
• High Laboratory Accreditation Costs
• Limited Skilled Bioinformatics Workforce
• Rising Energy Costs for Research Facilities
• Automation in Clinical Sequencing Laboratories
• Industrial Genomics Applications
The France represented approximately 15.6% of the European market in 2025 and was valued at nearly USD 83.6 million. Market growth is supported by government genomics investments, increasing oncology biomarker testing, expanding public research institutions, and rising adoption of next-generation sequencing technologies.
• National Genomic Medicine Investments
• Growth of Oncology Biomarker Testing
• Expanding Public Research Institutes
• Increasing Adoption of Clinical Sequencing
• Slow Hospital Technology Procurement
• Limited Private Sequencing Capacity
• Complex Reimbursement Approval Processes
• Regional Infrastructure Gaps
• Expansion of Infectious Disease Genomics
• Public-Private Sequencing Collaborations
Italy accounted for approximately 8.6% of the European market in 2025 and was valued at around USD 46.1 million. Market growth is driven by increasing hereditary disease diagnostics, expanding university genomics research, rising clinical sequencing demand, and continuous investments in molecular medicine.
• Rising Demand for Hereditary Disease Testing
• Strengthening Biomedical Research Programs
• Expansion of University Sequencing Centers
• Increasing Clinical Research Activities
• Uneven Regional Genomics Infrastructure
• Budget Constraints in Public Hospitals
• Low Laboratory Automation Levels
• Limited Access to Advanced Library Preparation Systems
• Southern Italy Genomics Expansion
• Precision Medicine Research Grants
The Spain represented approximately 8.2% of the European market in 2025 and was valued at nearly USD 43.9 million. Market growth is supported by expanding biomedical research, increasing precision oncology adoption, rising rare disease diagnostics, and growing investments in genomic healthcare infrastructure.
• Expanding National Cancer Research Programs
• Increasing Genomic Diagnostics Adoption
• Growth of Biomedical Innovation Clusters
• Rising Rare Disease Research
• Public Healthcare Budget Limitations
• Dependence on Imported Sequencing Consumables
• Laboratory Capacity Imbalances
• Lengthy Technology Adoption Cycles
• Digital Genomics Infrastructure Development
• Clinical Trial Sequencing Services
Switzerland accounted for approximately 3.1% of the European market in 2025 and was valued at around USD 16.6 million. Market growth is fueled by strong pharmaceutical innovation, expanding translational genomics research, increasing clinical sequencing applications, and continuous development of advanced molecular diagnostic technologies.
• World-Class Life Sciences Research
• Strong Pharmaceutical Innovation Ecosystem
• High Investment in Translational Genomics
• Advanced Clinical Laboratory Standards
• Premium Cost of Genomic Services
• Small Domestic Testing Volume
• Stringent Quality Assurance Requirements
• High Skilled Labor Costs
• Biopharma Sequencing Partnerships
• Advanced Single-Cell Genomics Research
The Netherlands represented approximately 2.1% of the European market in 2025 and was valued at nearly USD 11.2 million. Market growth is driven by integrated genomics programs, expanding multi-center sequencing research, increasing digital healthcare adoption, and growing investments in precision medicine initiatives.
• Integrated National Genomics Programs
• Strong Clinical Research Networks
• Increasing Multi-Center Sequencing Studies
• High Digital Healthcare Adoption
• Limited Domestic Manufacturing of Sequencing Reagents
• Dependence on Research Grant Funding
• Data Privacy Compliance Complexity
• Competition for Genomics Specialists
• Cloud-Enabled Genomic Workflows
• Precision Agriculture Sequencing Applications
Asia-Pacific accounted for approximately 22% of the global market in 2025 and was valued at nearly USD 472 million. Market growth is supported by expanding genome sequencing initiatives, increasing biotechnology investments, rising clinical NGS adoption, and improving healthcare infrastructure across emerging economies.
• Rapid Expansion of National Genome Sequencing Programs
• Growing Investments in Precision Medicine Infrastructure
• Rising Demand for Clinical NGS Testing
• Increasing Regional Biopharmaceutical Innovation
•Uneven Genomics Infrastructure Across Countries
• High Dependence on Imported Library Preparation Reagents
• Limited Standardization of NGS Workflows
• Shortage of Experienced Genomic Scientists
•Expansion of Regional Sequencing Manufacturing
•AI-Based Genomic Data Integration
China represented approximately 41.9% of the Asia-Pacific market in 2025 and was valued at around USD 197.8 million. Market growth is fueled by government-backed genomics programs, expanding domestic sequencing capabilities, increasing oncology testing, and rapid advancements in biotechnology manufacturing.
• Government Support for Genomic Technology Localization
• Expanding Domestic Sequencing Platform Manufacturing
• Increasing Oncology Genomic Screening
• Growth of Large-Scale Population Genomics Projects
• Export Restrictions on Critical Sequencing Components
• Regulatory Approval Complexity for Clinical Assays
• Intellectual Property Challenges
• Variability in Laboratory Quality Standards
• Development of Indigenous Library Preparation Kits
• Expansion of Multi-omics Clinical Research
India accounted for approximately 7.6% of the Asia-Pacific market in 2025 and was valued at nearly USD 35.8 million. Market growth is driven by expanding genomics research, increasing molecular diagnostics adoption, rising government healthcare initiatives, and growing biotechnology startup investments.
• Rising Genomic Medicine Initiatives
• Growing Number of NGS Service Laboratories
• Increasing Rare Disease Diagnosis Programs
• Expansion of Biotechnology Startup Ecosystem
• Limited Reimbursement for Genomic Diagnostics
• Inadequate Rural Genomics Infrastructure
• High Cost of Imported Sequencing Consumables
• Shortage of Certified Molecular Geneticists
• Local Manufacturing of NGS Reagents
• Government-Supported Precision Healthcare Programs
Japan represented approximately 15.8% of the Asia-Pacific market in 2025 and was valued at around USD 74.5 million. Market growth is supported by precision medicine initiatives, increasing long-read sequencing adoption, advanced clinical research infrastructure, and growing demand for companion diagnostics.
• Strong Demand for Companion Diagnostic Testing
• Advanced Clinical Research Infrastructure
• Increasing Adoption of Long-Read Sequencing
• Government Support for Genomic Healthcare
• Aging Laboratory Workforce
• High Validation Standards for Clinical Library Preparation
• Elevated Operational Costs in Research Institutions
• Conservative Adoption of Emerging Technologies
• Single-Cell Sequencing Innovation
• Expansion of Regenerative Medicine Genomics
South Korea represented approximately 14.3% of the Asia-Pacific market in 2025 and was valued at around USD 67.5 million. Market growth is fueled by government precision medicine programs, expanding biotechnology innovation, increasing cancer genomics research, and rapid adoption of advanced sequencing technologies.
• Strong Government Investment in Precision Medicine
• Expanding Biopharmaceutical Clinical Trials
• Advanced Digital Healthcare Ecosystem
• Growth of Cancer Genome Research
• Limited Domestic Availability of Specialized Consumables
• Dependence on Premium Imported Instruments
• Competitive Research Funding Environment
• Regulatory Complexity for Clinical Sequencing
• Smart Laboratory Automation Solutions
• Integration of Genomics with Digital Health Platforms
Singapore accounted for approximately 3.6% of the Asia-Pacific market in 2025 and was valued at nearly USD 16.9 million. Market growth is driven by strong biomedical research funding, international genomics collaborations, expanding translational medicine programs, and increasing clinical sequencing capabilities.
• Regional Hub for Biomedical Research
• High Government Funding for Genomics Innovation
• Strong International Research Collaborations
• Expansion of Translational Medicine Programs
• Limited Domestic Patient Population
• High Laboratory Operating Costs
• Dependence on Global Supply Chains
• Talent Competition in Life Sciences
• Asia-Pacific Genomics Collaboration Hub
• Development of Clinical Sequencing Centers of Excellence
Australia represented approximately 5.2% of the Asia-Pacific market in 2025 and was valued at around USD 24.5 million. Market growth is supported by national genomic healthcare initiatives, increasing cancer diagnostics, expanding academic sequencing research, and growing investments in precision medicine.
• National Investment in Genomic Healthcare
• Growing Demand for Precision Cancer Diagnostics
• Expansion of Academic Sequencing Facilities
• Increasing Public Health Genomics Research
• Geographic Challenges in Sample Transportation
• Limited Local Manufacturing of Sequencing Reagents
• High Cost of Clinical Genomic Services
• Workforce Shortages in Regional Areas
•Expansion of Rural Genomic Testing Networks
• Indigenous Population Genomics Research
Thailand represented approximately 1.3% of the Asia-Pacific market in 2025 and was valued at around USD 6.1 million. Market growth is driven by government healthcare modernization, increasing molecular diagnostics adoption, expanding biotechnology research, and rising investments in genomic medicine.
• Government Focus on Genomic Medicine Development
• Expansion of Medical Research Institutions
• Rising Clinical Adoption of NGS Technologies
• Growth of Biotechnology Investments
• Limited Advanced Sequencing Infrastructure
• Dependence on Imported Library Preparation Products
• Budget Constraints in Public Hospitals
• Insufficient Bioinformatics Expertise
• Medical Tourism Genomics Services
• Regional Clinical Research Collaborations
Malaysia accounted for approximately 2.5% of the Asia-Pacific market in 2025 and was valued at nearly USD 11.8 million. Market growth is fueled by expanding biotechnology research, increasing personalized medicine adoption, growing university genomics programs, and improving molecular diagnostics capabilities.
• Growing Molecular Diagnostics Market
• Increasing Investment in Biotechnology Research
• Expansion of University Genomics Programs
• Rising Demand for Personalized Medicine
• Limited High-Throughput Sequencing Facilities
• Imported Reagent Price Volatility
• Inconsistent Research Funding
• Shortage of Specialized Laboratory Personnel
• Halal Pharmaceutical Genomics Research
• Public-Private Genomics Innovation Partnerships
Philippines represented approximately 2% of the Asia-Pacific market in 2025 and was valued at around USD 9.4 million. Market growth is supported by strengthening disease surveillance programs, increasing molecular diagnostics adoption, expanding healthcare modernization, and rising investments in genomic research.
• Expansion of National Disease Surveillance Programs
• Growing Adoption of Molecular Diagnostics
• Rising Government Healthcare Modernization
• Increasing Academic Genomics Research
• Limited Clinical Sequencing Capacity
• High Dependence on External Testing Services
• Budget Limitations for Advanced Diagnostics
• Lack of Standardized Genomics Training
• Expansion of Infectious Disease Sequencing
• Development of Local Reference Genomic Databases
Indonesia represented approximately 1.6% of the Asia-Pacific market in 2025 and was valued at around USD 7.5 million. Market growth is driven by increasing infectious disease genomics, expanding biotechnology initiatives, improving healthcare infrastructure, and growing adoption of precision medicine technologies.
• Growing Demand for Infectious Disease Genomics
• Increasing Healthcare Infrastructure Development
• Expansion of National Biotechnology Programs
• Rising Interest in Precision Medicine
• Archipelagic Sample Logistics Challenges
• Limited Access to Advanced Sequencing Facilities
• Dependence on Imported NGS Consumables
• Low Awareness of Clinical Genomics
• Population Diversity Genomics Research
• Government Expansion of Genomic Laboratory Networks
Middle East & Africa accounted for approximately 4.8% of the global market in 2025 and was valued at nearly USD 103 million. Market growth is supported by national genomics initiatives, increasing precision healthcare investments, expanding genetic disease diagnostics, and strengthening molecular research capabilities.
• Expanding National Genomics Strategies
• Growing Investment in Precision Healthcare
• Rising Prevalence of Genetic Disorders
• Increasing Public Health Genomic Surveillance
• Limited Regional Sequencing Infrastructure
• Dependence on Imported Library Preparation Reagents
• Shortage of Genomics Specialists
• Uneven Healthcare Funding Across Countries
• Establishment of Regional Genomics Centers
• International Genomics Research Partnerships
Saudi Arabia accounted for approximately 32.8% of the Middle East market in 2025 and was valued at nearly USD 33.7 million. Market growth is driven by Vision 2030 healthcare transformation, expanding national genome programs, increasing inherited disease screening, and growing biotechnology investments.
• Vision 2030 Healthcare Transformation
• National Human Genome Program Expansion
• Rising Demand for Inherited Disease Screening
• Government Investment in Biotechnology Parks
• Limited Domestic Manufacturing of NGS Consumables
• Dependence on Foreign Technical Expertise
• High Procurement Costs for Sequencing Systems
• Clinical Validation Capacity Constraints
• Local Production of Genomics Reagents
• Expansion of Precision Oncology Services
United Arab Emirates represented approximately 25.9% of the Middle East market in 2025 and was valued at around USD 26.6 million. Market growth is fueled by national genome initiatives, increasing precision medicine adoption, expanding biotechnology investments, and growing demand for advanced molecular diagnostics.
• Rapid Adoption of Precision Medicine
• Expansion of National Genome Initiatives
• Increasing Investments in Advanced Diagnostics
• Strong Government Support for Biotechnology
• Small Domestic Research Population
• High Cost of Specialized Genomics Laboratories
• Dependence on Imported Sequencing Consumables
• Talent Retention Challenges
• Regional Hub for Clinical Genomics
• AI-Enabled Personalized Healthcare Solutions
South Africa represented approximately 15.1% of the Middle East market in 2025 and was valued at around USD 15.5 million. Market growth is supported by expanding infectious disease genomics, increasing academic sequencing research, growing cancer genomics studies, and strengthening healthcare research investments.
• Growing Infectious Disease Genomics Research
• Expansion of Academic Sequencing Facilities
• Increasing Government Health Research Funding
• Rising Cancer Genomics Studies
• Limited Access to High-End Sequencing Platforms
• Public Healthcare Budget Constraints
• Inadequate Rural Genomic Testing Access
• Supply Chain Delays for Laboratory Reagents
• African Population Genomics Studies
• International Clinical Research Collaborations
Egypt accounted for approximately 8.2% of the Middle East & Africa market in 2025 and was valued at nearly USD 8.4 million. Market growth is driven by healthcare modernization, increasing molecular biology research, expanding genetic disease diagnostics, and growing investments in academic genomics programs.
• Expanding National Healthcare Modernization
• Increasing Academic Molecular Research
• Rising Demand for Genetic Disease Diagnostics
• Growth in University Research Laboratories
• Limited Funding for Advanced Sequencing Projects
• Dependence on Imported Laboratory Kits
• Low Clinical Adoption of Precision Medicine
• Limited Bioinformatics Infrastructure
• Expansion of Prenatal Genomic Testing
• Regional Biotechnology Investment Programs
Israel represented approximately 7.2% of the Middle East and Africa market in 2025 and was valued at around USD 7.4 million. Market growth is fueled by advanced biotechnology innovation, strong precision medicine research, increasing clinical genomics adoption, and robust investments in life sciences.
• Strong Precision Medicine Research Ecosystem
• Advanced Biotechnology Innovation
• High Clinical Adoption of Genomic Diagnostics
• Robust Venture Capital Support for Genomics
• Rising Cost of Genomic Research Activities
• Limited Domestic Market Size
• Increasing Data Privacy Compliance Requirements
• Competition for Skilled Researchers
• Development of Novel Library Preparation Chemistries
• Expansion of Multi-omics Drug Discovery
Latin America accounted for approximately 3.1% of the global market in 2025 and was valued at around USD 66.5 million. Market growth is supported by increasing molecular diagnostics adoption, expanding genomics research collaborations, rising cancer diagnostics demand, and improving healthcare infrastructure investments.
• Increasing Government Investment in Molecular Diagnostics
• Growing Burden of Cancer and Rare Diseases
• Expanding Genomic Research Collaborations
• Rising Adoption of Clinical NGS Technologies
• Limited Access to High-Throughput Sequencing Facilities
• Economic Instability Affecting Research Spending
• Heavy Dependence on Imported Reagents
• Regulatory Heterogeneity Across Countries
• Regional Precision Medicine Programs
• Expansion of Local Sequencing Service Providers
Brazil accounted for approximately 32.9% of the Latin America market in 2025 and was valued at nearly USD 21.8 million. Market growth is driven by expanding genomics research programs, increasing precision oncology adoption, strong agricultural genomics applications, and growing clinical sequencing activities.
• Expanding National Genomic Research Programs
• Strong Agricultural Genomics Applications
• Growing Precision Oncology Adoption
• Increasing Clinical Research Activities
• High Import Duties on Laboratory Equipment
• Regional Healthcare Infrastructure Disparities
• Complex Regulatory Approval Procedures
• Currency Fluctuations Affecting Reagent Costs
• Local Manufacturing of Library Preparation Kits
• Large-Scale Population Genomics Projects
Mexico accounted for approximately 23.5% of the Latin America market in 2025 and was valued at nearly USD 15.6 million. Market growth is fueled by expanding clinical molecular diagnostics, increasing pharmaceutical research, growing genomics programs, and rising investments in precision healthcare.
• Increasing Public Health Genomics Programs
• Growth of Clinical Molecular Diagnostics
• Rising Pharmaceutical Research Investments
• Expanding University Genomics Centers
• Limited Reimbursement for Advanced Genomic Testing
• Dependence on Imported Sequencing Technologies
• Uneven Laboratory Capacity
• Shortage of Clinical Genomics Professionals
• Cross-Border Genomics Research Initiatives
• Expansion of Companion Diagnostic Testing
Argentina represented approximately 10.6% of the Latin America market in 2025 and was valued at around USD 7 million. Market growth is supported by strong biomedical research, increasing rare disease diagnostics, expanding government science funding, and growing precision medicine initiatives.
• Strong Biomedical Research Institutions
• Increasing Rare Disease Research
• Rising Adoption of Precision Diagnostics
• Expansion of Government Science Funding
• Economic Volatility Affecting Laboratory Investments
• Imported Reagent Supply Challenges
• Limited Commercial Sequencing Infrastructure
• Brain Drain of Genomics Experts
• Academic-Industry Genomics Partnerships
• Expansion of Translational Medicine Research
Chile represented approximately 8.6% of the Latin America market in 2025 and was valued at around USD 5.7 million. Market growth is driven by expanding biomedical innovation, increasing precision oncology programs, strengthening scientific research, and growing adoption of genomic diagnostic technologies.
• Growing Investment in Biomedical Innovation
• Expansion of Precision Oncology Programs
• Increasing Government Support for Scientific Research
• Rising Genomic Disease Surveillance
• Limited Domestic Production of Sequencing Consumables
• Small Clinical Sequencing Market
• High Cost of Advanced Molecular Diagnostics
• Dependence on International Suppliers
• National Biobank Development
• Precision Medicine Research Collaborations
Colombia accounted for approximately 5.2% of the Latin America market in 2025 and was valued at nearly USD 3.4 million. Market growth is fueled by expanding molecular diagnostics infrastructure, increasing cancer genomic testing, growing university research activities, and rising healthcare technology investments.
• Expanding Molecular Diagnostics Infrastructure
• Rising Demand for Cancer Genomic Testing
• Growth in University Research Programs
• Increasing Healthcare Technology Investments
• Limited Genomics Laboratory Network
• Budget Constraints in Public Healthcare
• Dependence on Imported NGS Products
• Regulatory Delays for New Technologies
• Expansion of Clinical Sequencing Services
• Development of National Genomic Databases
Peru represented approximately 4.3% of the Latin America market in 2025 and was valued at around USD 2.8 million. Market growth is supported by expanding public health genomics, increasing genetic disease research, strengthening clinical laboratory capabilities, and growing international genomics collaborations.
• Increasing Government Focus on Genetic Disease Research
• Growth of Public Health Genomics
• Rising Academic Collaboration in Molecular Biology
• Expanding Clinical Laboratory Capabilities
• Limited Access to Advanced Sequencing Centers
• Shortage of Specialized Genomics Workforce
• High Cost of Imported Sequencing Kits
• Inadequate Bioinformatics Capacity
• Genomic Research on Indigenous Populations
• International Funding for Genomics Infrastructure
|
Company |
Share |
|
Illumina, Inc. |
21.8% |
|
Thermo Fisher Scientific Inc. |
14.2% |
|
Agilent Technologies, Inc. |
10.8% |
|
F. Hoffmann-La Roche Ltd. |
8.3% |
|
Danaher Corp. |
7.3% |
The global Next-generation Sequencing Library Preparation Market is moderately consolidated, with the top five players accounting for approximately 62.4% of the global market. Illumina, Thermo Fisher Scientific, Agilent Technologies, Roche, and Danaher maintain leadership through comprehensive library preparation portfolios, automation platforms, strategic acquisitions, and strong partnerships with clinical, pharmaceutical, and academic research institutions.
Our research framework strategically segments the Next-generation Sequencing Library Preparation market by Offerings, Application, Technology (Platforms), Type (Products), Workflow (Product), End User (Products), Type (Services), Workflow (Services), End User (Services) and key regional markets
|
Key Report Attributes |
Details |
|
Years Considered |
2022 to 2035 |
|
Market Size 2025 |
USD 2145.9 Million |
|
Market Size 2035 |
USD 8010.9 Million |
|
Historical CAGR% (Growth rate) |
12.3% from 2022 to 2025 |
|
Futuristic CAGR% (Growth rate) |
14.08% from 2026 to 2035 |
|
Segments Covered |
|
|
Regions Covered |
|
|
Countries Covered |
USA; Canada; Germany; United Kingdom; France; Italy; Spain; Switzerland; Netherlands; China; India; Japan; South Korea; Singapore; Australia; Thailand; Malaysia; Philippines; Indonesia; Saudi Arabia; United Arab Emirates; South Africa; Egypt; Israel; Brazil; Mexico; Argentina; Chile; Colombia; Peru |
|
Competitive Landscape Overview |
|
|
Flexible Report Customization |
The study can be customized based on geography, segment analysis, company profiling, competitive benchmarking, and strategic insights. |
|
Data Sources |
Primary and secondary sources used (Company filings, trade associations, Journals, Annual report, Publications, Surveys, Investor Presentations, and much more. |
Related Reports
+44 1313818849
sales@brandessenceresearch.com
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com
JOIN USFIND ASSISTANCE
INDIA OFFICE
BrandEssence® Market Research and Consulting Pvt ltd.
408B, City Center, Hadapsar, Pune, India 411028
FOLLOW US
© Copyright 2026-27 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®